Yale Medicine is making great strides in helping women who are diagnosed with “high-risk” pregnancies. We offer state-of-the-art approaches to caring for women with medical conditions that can complicate a pregnancy.
Our providers are experts in caring for women with preeclampsia and their babies. Our program focuses on the short- and long-term burden of the disease for the mother and the baby, with an emphasis on emerging treatment options for preeclampsia and related disorders such as fetal growth restriction and prematurity.
The cause of preeclampsia is currently unknown, and the incidence of severe preeclampsia is increasing rapidly; the condition is a leading cause of maternal and newborn deaths in the United States. At present, delivery of the baby is the only known way to stop the progression of preeclampsia. Without intervention, preeclampsia can escalate to multi-organ failure, seizures, coma, or death of the mother and baby.
As a result of these alarming statistics, our program is fully dedicated to preeclampsia patient care and research initiatives. Our program is also a great resource for educating pregnant women and healthcare providers about preeclampsia. Information is disseminated through a variety of channels, including medical conferences, continuing medical education courses, and social and print media.